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Gel-filtrated human platelets were stimulated with thrombin  the absence and presence of adrenaline. Adrenaline 
markedly enhanced the thrombin-induced increase in cytoplasmic pH (pHJ in BCECF-loaded platelets. This rise in pH, 
was strongly inhibited by the Na+/H+ exchange blocker EIPA. The potentiation by adrenaline of thrombin-induced PLC 
activation measured as P*P]PA formation and final platelet responses was, however, not blocked by EIPA, even at low 
concentrations of thrombin. These results indicate that the enhancement by adrenaline of thrombin-induced cytoplasmic 
alkalinization may be a secondary effect which is not essential for the potentiation by adrenaline of platelet activation 
by thrombin. 
Na+/H+ exchange; PLC activation; Aggregation; Secretion 
1. INTRODUCTION 
The mechanism of adrenaline-mediated human 
platelet activation has been subject to much debate 
during the last decade. Especially, it has not been 
clearly established whether adrenaline is a platelet 
stimulator per se or only potentiates responses in- 
duced by other platelet agonists. 
Therefore, the demonstration that adrenaline by 
itself induces cytoplasmic alkalinization via activa- 
tion of the Na+/H+ antiport attracted great in- 
terest, especially since it was shown that this rise in 
pHi is parallelled by phospholipase A2 activation 
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[ 1,2], thereby constituting a possible pathway for 
adrenaline-mediated platelet activation. 
Recently it was reported that adrenaline reverses 
thrombin-induced homologous desensitization of 
human platelets, and this resensitization is not in- 
hibited by the Na+/H+-exchange blocker EIPA 
[3,4]. These results indicated that adrenaline did 
not affect platelet activation through an effect on 
pHi. In the present paper we have investigated 
whether adrenaline may potentiate thrombin- 
induced cytoplasmic alkalinization, and determin- 
ed the importance of this mechanism during poten- 
tiation by adrenaline of thrombin-induced platelet 
activation. 
2. MATERIALS AND METHODS 
2.1. Materials 
Stock solutions of bovine thrombin (Hoffman-La Roche), 
adrenaline (Sigma), acetylsalicylic acid (Sigma), nigericin 
(Sigma; prepared in DMSO), BCECF-AM (Molecular Probes 
Inc.) and EIPA (a gift from Dr W. Siffert), both prepared in 
DMSO, were stored at -20°C. Solutions of CP (Sigma) and 
CPK (Sigma; type I, rabbit muscle) were freshly prepared in 
Tyrodes solution. [32P]Orthophosphate was purchased from 
Amersham (code PBS-l 1, carrier-free). 
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2.2. Platelet isolation, labelling and incubation 3. RESULTS 
Platelet-rich plasma (PRP) was prepared by differential cen- 
trifugation of freshly drawn human venous blood antico- 
agulated with ACD [5]. For the phosphoinositide xperiments, 
PRP was incubated with [‘*PIPi (0.1 mCi/ml) for 60 min at 
37°C. In the experiments designed to measure cytoplasmic pH 
(pHi), the platelet pellet was resuspended in a Hepes-modified 
Tyrode’s buffer (10 mM Hepes, 0.02% BSA, 5 mM glucose, 
pH 6.5) and incubated with the fluorescent probe BCECF for 
approx. 60 min at 37°C. BCECF was added as its tetra- 
acetooxymethyl ester (BCECF-AM; 10 PM final cont.). In all 
experiments, acetylsalicylic acid (1 mM final cont.) was added 
to the platelet suspension during the last 15 min of the different 
preincubation procedures. The platelets were transferred by gel- 
filtration through Sepharose 2B to a Hepes-modified, nominal- 
ly HCOY free Tyrode’s buffer (10 mM Hepes, 0.2% BSA, 
5 mM glucose, pH 7.3) which also contained CP (5 mM)/CPK 
(10 U/ml). In the phospholipid experiments, the buffer was 
nominally Pi-free. The platelet concentration was either stan- 
dardized at 3.5 x IO* cells/ml for phosphoinositide, aggrega- 
tion and secretion experiments or at 1 .O x lo8 cells/ml for pHi 
determination. In all experiments, uspensions of platelets were 
preincubated with DMSO (control; 0.1%) or EIPA (10 pM; 
0.1% DMSO) for 10 min at 37°C before the addition of 
agonist(s). Adrenaline was always added 10 s prior to 
thrombin. 
3.1. Adrenaline potentiates thrombin-induced 
elevation Of PHi 
2.3. Determination of pHi 
Fig.1 shows typical changes in the fluorescence 
signal in BCECF-loaded platelets upon stimulation 
with thrombin and adrenaline. Resting pHi value 
was 7.25 + 0.03 (n = 7; + SD). The fluorescence 
signal did not increase by adrenaline alone (10 PM) 
under the conditions used (fig.la). Thrombin 
alone (0.10 U/ml) induced a minimal initial 
decrease of pHi (<0.02 pH units) followed by a 
slow alkalinization to 0.06 pH units (2 min after 
stimulation) above the initial value (fig.lb). The 
presence of adrenaline (10 PM) markedly enhanced 
the thrombin-induced alterations of pHi, demon- 
strated by an initial drop in fluorescence (0.05 pH 
units) followed by a more rapid alkalinization to 
0.06 pH units above resting value. Only the rate 
but not the final extent of the alkalinization was in- 
creased by the presence of adrenaline (fig. Ic). The 
increase in pHi induced by thrombin alone (not 
shown) and by adrenaline plus thrombin was 
The fluorescence xperiments were performed without stir- 
ring at 37°C in a Perkin-Elmer LS 5 luminescence spec- 
trometer. Excitation and emission were at 495 nm and 530 nm, 
respectively, using bandwidths of 5 nm. Samples of BCECF- 
loaded platelets were stimulated after a stable fluorescence 
signal had been established. The pHi measurements recorded as 
changes in fluorescence were calibrated according to Horne et 
al. [6], using a Hepes-buffer with 120 mM KCl, 25 mM NaCl 
and 2 PM nigericin. BCECF fluorescence was linear with pH in 
the pH range investigated (6.9-7.4). Saline (0.15 M NaCl) 
alone did not change the fluorescence signal (not shown). The 
traces are representative of experiments with platelets from at 
least 4 different donors. 
2.4. Phosphohpid metabohkm 
0.5 ml samples were withdrawn from the unstirred suspen- 
sions (37“C) 90 s after the addition of agonist, and mixed with 
2.0 ml chloroform/methanol/cone. HCl (20:40: 1, by vol.; 
O’C). The further processing of the samples, including separa- 
tion by thin-layer chromatography and determination of 
radioactivity of the phospholipids were performed as described 
IS]. The results are expressed as a percentage of the saline- 
treated (control) platelets. 
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2.5. Aggregation and dense granule secretion 
Aggregation was recorded as change in optical density of the 
platelet suspension, using a Payton dual-channel aggregation 
module [7]. Dense granule secretion was determined after 75 s 
of incubation as the extracellular appearance of ADP plus 
ATP, measured by a luciferin-luciferase method [7]. The results 
are representative of identical experiments from 6 different 
donors. 
Fig.1. Changes in the cytoplasmic pH induced by adrenaline 
and thrombin in the absence or presence of EIPA. BCECF- 
loaded platelets were stimulated with (a) adrenaline (10 pM), (b) 
thrombin (0.10 U/ml), (c) adrenaline (10pM) and thrombin 
(0.10 U/ml), or (d) EIPA (10 FM) plus adrenaline (10 FM) and 
thrombin (0.10 U/ml). The agonists were added as indicated by 
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Fig.2. The effect of EIPA on [“PIPA formation induced by 
thrombin alone and by adrenaline plus thrombin. [“PIPi- 
prelabelled platelets were stimulated with saline or increasing 
concentrations of thrombin (U/ml) with (closed bars) or 
without (open bars) adrenaline (10 PM) in the absence (-) or 
presence (+) of EIPA (10 ,uM). The paired Student f-test was 
used to determine whether or not adrenaline significantly 
enhanced the thrombin-induced 13’P]PA formation (n = 6; P < 
0.05 indicated by asterisks). 
Fig.3. The effect of EIPA on the potentiation by adrenaline on 
thrombin-induced aggregation and dense granule secretion. 
Platelet suspensions were stirred at 400 rpm and stimulated 
with saline or thrombin (T; 0.05 or 0.10 U/ml) with (+) or 
without (-) adrenaline (A; 10 FM) in the absence or presence 
of EIPA (10pM). The degree of secretion is indicated as a 
percentage of the total content of ADP plus ATP in the 
platelets. 
strongly inhibited by the Na+/H+-antiport blocker 
EIPA (10 /LM; fig. Id). 
3.2. The potentiation by adrenaline of thrombin- 
induced p2P]PA formation, aggregation and 
dense granule secretion is not blocked by 
EIPA 
Fig.2 shows that the presence of EIPA (10 PM) 
had no inhibitory effect on the potentiation by 
adrenaline of thrombin-induced phospholipase C 
activation measured as [32P]PA formation, 
Similarly, the potentiating action of adrenaline on 
thrombin-induced final platelet responses (ag- 
gregation and dense granule secretion) persisted 
during blockage of the Na+/H+ exchange by EIPA 
(fig.3). The results were independent of whether or 
not the platelets 
BCECF. 
4. DISCUSSION 
had been preincubated with 
It has been well documented that the platelet- 
stimulating effect of adrenaline is mediated via 
alphaz-adrenergic receptors [8]. Activation of these 
receptors in human platelets inhibits the adenylate 
cyclase system through coupling via a Gi-protein 
[9], but this effect is probably not involved in 
platelet stimulation [lo- 121. Moreover, it is clearly 
established that adrenaline potentiates phospho- 
lipase C activation induced by several platelet 
agonists [5,13-151, although there is no conclusive 
evidence that adrenaline stimulates PLC directly. 
As a consequence, the recent demonstration that 
adrenaline may induce cytoplasmic alkalinization 
via activation of the Na+/H+ exchange mechanism 
[1,2] offered a challenging proposal: this rise in 
pHi was shown to trigger a sequence of events, in- 
volving arachidonate liberation by phospholipase 
AZ, followed by formation of platelet-stimulating 
prostaglandins and thromboxanes by the cycloox- 
ygenase pathway, which finally activated PLC. 
In the present paper we show that adrenaline 
may potentiate thrombin-induced cytoplasmic 
alkalinization via the Na+/H+ antiport mechan- 
ism. Adrenaline by itself did not activate the 
Na+/H+ exchange, which is in contrast to the 
results obtained by Sweatt et al. [1,2]. This 
discrepancy may be explained by the use of 
cyclooxygenase inhibitor, removal of extracellular 
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ADP by CP/CPK as well as the nominal absence 
of fibrinogen in our. experiments [13,16,17]. 
The presence of the Na+/H+ antiport blocker 
EIPA strongly inhibited the rise in pHi induced 
either by thrombin alone or by the association of 
adrenaline and thrombin. However, EIPA did not 
alter the potentiating action of adrenaline on 
thrombin-induced PLC activation measured as 
[32P]PA formation and final platelet responses. 
Also, it was recently demonstrated that adrenaline 
may reverse thrombin-mediated homologous 
desensitization in human platelets even in the 
presence of EIPA [3,4]. Therefore, the mechanism 
involved in the potentiation by adrenaline of 
thrombin-induced responses does not require ac- 
tivation of the Na+/H” exchange mechanism, even 
at low concentrations of thrombin. 
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